[Principles of Transparency
and Best Practice]
1) The URL address of official journal web site is https://clinicalhypertension.biomedcentral.com/
2) Aims & Scope
Clinical Hypertension is a peer-reviewed, open access journal that aims to publish in all areas of hypertension and vascular disorders. We aim to ensure the widest possible dissemination of research throughout the hypertension community.
The journal focuses on areas within vascular biology, cellular and molecular biology, clinical hypertension, epidemiology, nephrology, endocrinology, neuroscience, pharmacology, genetics, pediatric hypertension and basic science.
Authorship provides credit for a researcher’s contributions to a study and carries accountability. Authors are expected to fulfil the criteria below (adapted from McNutt et al.,Proceedings of the National Academy of Sciences, Feb 2018, 201715374; DOI: 10.1073/pnas.1715374115; licensed under CC BY 4.0):
Each author is expected to have made substantial contributions to the conception OR design of the work; OR the acquisition, analysis, OR interpretation of data; OR the creation of new software used in the work; OR have drafted the work or substantively revised it
AND to have approved the submitted version (and any substantially modified version that involves the author's contribution to the study);
AND to have agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
BMC journals encourage collaboration with colleagues in the locations where the research is conducted, and expect their inclusion as co-authors when they fulfill all authorship criteria described above. Contributors who do not meet all criteria for authorship should be listed in the Acknowledgements section.
Please see individual journal's Submission Guidelines for information on the format for listing author contributions.
Authors wishing to make changes to authorship will be asked to complete our change of authorship form. Please note that changes to authorship cannot be made after acceptance of a manuscript.
Corresponding authors are responsible for ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors, and that all authors receive the submission and all substantive correspondence with editors, as well as the full reviews, verifying that all data, figures, materials (including reagents), and code, even those developed or provided by other authors, comply with the transparency and reproducibility standards of both the field and journal.
This responsibility includes but is not limited to: (i) ensuring that original data/original figures/materials/code upon which the submission is based are preserved following best practices in the field so that they are retrievable for reanalysis; (ii) confirming that data/figures/materials/code presentation accurately reflects the original; and (iii) foreseeing and minimizing obstacles to the sharing of data/materials/code described in the work. The corresponding author should be responsible for managing these requirements across the author group and ensuring that the entire author group is fully aware of and in compliance with best practices in the discipline of publication.
To discourage ghost authorship, corresponding authors must reveal as appropriate whether the manuscript benefited from the use of editorial services that, if unacknowledged, might constitute an undisclosed conflict of interest. Examples include use of an editor from an organization that may have a vested interest in slanting the results or reliance on a technical writer at a level that would warrant authorship credit. These situations might variously be addressed by including a statement in the acknowledgments, by describing the effort in the methods section, or by adding an author.
The involvement of scientific (medical) writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding, as described in the European Medical Writers Association (EMWA) guidelines. The role of medical writers should be acknowledged explicitly in the ‘Acknowledgements’ or ‘Authors’ contributions’ section as appropriate.
Corresponding authors should indicate whether any authors on earlier versions have been removed or new authors added and why. It is incumbent on the corresponding author to ensure that all authors (or group/laboratory leaders in large collaborations) have certified the author list and contribution description: that all authors who deserve to be credited on the manuscript are indeed identified, that no authors are listed who do not deserve authorship credit, and that author contributions, where they are provided, are expressed accurately.
Any potential authorship disputes brought to the editors’ attention will be handled in line with COPE guidelines.
4) pISSN: 2635-6325 eISSN: 2056-5909
The official journal title is Clinical Hypertension. Abbreviated title is Clin Hypertens
Clinical Hypertension is a continuation of Journal of the Korean Society of Hypertension.
All research articles, and most other article types, published in BMC journals undergo thorough peer review. This usually involves review by two independent peer reviewers. Individual journals may differ in their peer review processes; for example, some journals operate an open and others a closed peer review system. For an individual journal’s peer review policy, please see the journal's 'About' page.
Peer review policy
All submissions to BMC journals are assessed by an Editor, who will decide whether they are suitable for peer review. Where an Editor is on the author list or has any other competing interest regarding a specific manuscript, another member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. Submissions felt to be suitable for consideration will be sent for peer review by appropriate independent experts identified by the Handling Editor. Editors will make a decision based on the reviewers’ reports and authors are sent these reports along with the editorial decision on their manuscript. Authors should note that even in light of one positive report, concerns raised by another reviewer may fundamentally undermine the study and result in the manuscript being rejected.
1) Information about the ownership: This journal is owned by the publisher, the Korean Society of Hypertension. http://www.koreanhypertension.org/eng/intro/intro
2) Management team of a journal (2017-2021)
Wook-Jin Chung, Gachon University College of Medicine, Republic of Korea
Hyun-Jai Cho, Seoul National University College of Medicine, Republic of Korea
Jin Oh Na, Korea University College of Medicine, Republic of Korea
Jae-Hyeong Park, Choongnam National University College of Medicine, Republic of Korea
The governing body is the journal's editorial board.
1) Editorial team is available from Editorial board list of the journal.
2) Contact information
(a) Wook-Jin Chung(Editor-in-Chief)
Gachon University College of Medicine, Republic of Korea
(b) Tae-Hee Kim(Editorial staff)
The Korean Society of Hypertension
1504 LG Twintel 2 508, Samseong-ro, Gangnam-gu, Seoul, 06169, Republic of Korea
(c) For questions regarding submission or submitted manuscripts, contact editorial office via the
journal’s submission system (click ‘contact us’ link on the top banner).
As an author of an article published in Clinical Hypertension you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
▶ Copyright on any open access article in a journal published by BMC is retained by the author(s).
▶ Authors grant BMC a license to publish the article and identify itself as the original publisher.
▶ Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
▶ The Creative Commons Attribution License 4.0 formalizes these and other terms and conditions of publishing articles.
▶ In accordance with our Open Data policy, the Creative Commons CC0 1.0 Public Domain Dedication waiver applies to all published data in BMC open access articles.
Where an author is prevented from being the copyright holder (for instance in the case of US government employees or those of Commonwealth governments), minor variations may be required. In such cases the copyright line and license statement in individual articles will be adjusted, for example to state ‘© 2016 Crown copyright’. Authors requiring a variation of this type should inform BMC during or immediately after submission of their article. Changes to the copyright line cannot be made after publication of an article.
For further information about the advantages of publishing in a journal from BMC, please click here.
The Society is currently covering all publication costs so there are no article processing charges for authors.
BMC takes seriously all allegations of potential misconduct. As members of COPE, all BMC journals will follow the COPE guidelines outlining how to deal with cases of suspected misconduct.
In cases of suspected research or publication misconduct, it may be necessary for the Editor to contact and share manuscripts with third parties, for example, author(s)’ institution(s) and ethics committee(s). BMC may also seek advice from COPE and discuss anonymized cases in the COPE Forum. The editor may also involve BMC’s independent ombudsman.
A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
For all manuscripts that include details, images, or videos relating to an individual person, written informed consent for the publication of these details must be obtained from that person (or their parent or legal guardian in the case of children under 18). The consent must be for publication of their details under the Creative Commons Attribution License 4.0 (such that they will be freely available on the internet). If the person has died, consent for publication must be obtained from their next of kin. The manuscript must include a statement that written informed consent for publication was obtained.
Authors can use the BMC consent form to obtain consent for publication, or a consent form from their own institution or region if appropriate. The consent form must state that the details/images/videos will be freely available on the internet and may be seen by the general public. The consent form must be made available to the Editor if requested, and will be treated confidentially.
In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.
: The Clinical Hypertension is published twice a month (the 1st and 15th of every month).
: The Clinical Hypertension is published four times a year (Jan 1st, Apr 1st, Jul 1st, and Oct 1st).
Open access https://www.biomedcentral.com/about/open-access
All articles published by Clinical Hypertension are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Clinical Hypertension you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Archival content http://www.koreanhypertension.org/journal/previous2
Clinical Hypertension is a continuation of the Journal of the Korean Society of Hypertension. All previous contents (1995-2014) from the Journal of the Korean Society of Hypertension are freely available at its official website.
Revenue sources of journal are from the support of the Korean Society of Hypertension.
Journal propagation has been done through the journal web site and distribution of an introduction pamphlets on Hypertension conference. Invitations to submit a manuscript are usually focused on the speakers at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.